Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$2.91 - $4.83 $875,586 - $1.45 Million
-300,889 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$4.17 - $5.74 $1.21 Million - $1.66 Million
288,992 Added 2429.12%
300,889 $1.41 Million
Q1 2021

May 14, 2021

SELL
$5.28 - $9.64 $2.03 Million - $3.7 Million
-384,027 Reduced 97.0%
11,897 $63,000
Q4 2020

Feb 12, 2021

BUY
$5.75 - $7.13 $390,908 - $484,725
67,984 Added 20.73%
395,924 $2.58 Million
Q3 2020

Nov 12, 2020

SELL
$4.9 - $7.12 $869,064 - $1.26 Million
-177,360 Reduced 35.1%
327,940 $2 Million
Q2 2020

Aug 12, 2020

BUY
$6.43 - $9.86 $1.56 Million - $2.4 Million
243,232 Added 92.81%
505,300 $3.67 Million
Q1 2020

May 15, 2020

SELL
$6.36 - $10.05 $2.8 Million - $4.42 Million
-439,914 Reduced 62.67%
262,068 $1.82 Million
Q4 2019

Feb 13, 2020

BUY
$8.49 - $12.81 $2.49 Million - $3.76 Million
293,379 Added 71.8%
701,982 $6.19 Million
Q3 2019

Nov 14, 2019

BUY
$5.58 - $14.47 $2.28 Million - $5.91 Million
408,603 New
408,603 $4.58 Million
Q2 2019

Aug 14, 2019

SELL
$5.22 - $9.08 $2.61 Million - $4.54 Million
-499,674 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$5.35 - $9.82 $1.13 Million - $2.08 Million
-211,602 Reduced 29.75%
499,674 $3.93 Million
Q4 2018

Feb 14, 2019

BUY
$3.43 - $6.19 $2.39 Million - $4.31 Million
696,576 Added 4738.61%
711,276 $3.53 Million
Q3 2018

Nov 14, 2018

BUY
$4.75 - $14.5 $69,825 - $213,150
14,700 New
14,700 $70,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.